BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38634790)

  • 1. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor.
    Anwar MA; Keshteli AH; Yang H; Wang W; Li X; Messier HM; Cullis PR; Borchers CH; Fraser R; Wishart DS
    OMICS; 2024 Apr; 28(4):182-192. PubMed ID: 38634790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of pancreatic cancer using DNA-based molecular approaches.
    Singhi AD; Wood LD
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):457-468. PubMed ID: 34099908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
    Pang Y; Holmes MV; Chen Z; Kartsonaki C
    J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates of liquid biopsy in oral cancer and multiomics analysis.
    Zhang X; Li B
    Oral Dis; 2023 Jan; 29(1):51-61. PubMed ID: 34716963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Omics and Phenotypic Data for Precision Medicine.
    Zhao J; Feng Q; Wei WQ
    Methods Mol Biol; 2022; 2486():19-35. PubMed ID: 35437716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection markers in Pancreas Cancer.
    Farrell JJ; van Rijnsoever M; Elsaleh H
    Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics, artificial intelligence, and precision medicine in perinatology.
    Pammi M; Aghaeepour N; Neu J
    Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
    Jabbar KS; Arike L; Verbeke CS; Sadik R; Hansson GC
    J Clin Oncol; 2018 Feb; 36(4):367-375. PubMed ID: 29166170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
    Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
    Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.
    Kim K; Ku CR; Lee EJ
    Endocrinol Metab (Seoul); 2023 Oct; 38(5):463-471. PubMed ID: 37828709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for early detection of resectable pancreatic cancer.
    Okano K; Suzuki Y
    World J Gastroenterol; 2014 Aug; 20(32):11230-40. PubMed ID: 25170207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for pancreatic cancer has the potential to save lives, but is it practical?
    Mazer BL; Lee JW; Roberts NJ; Chu LC; Lennon AM; Klein AP; Eshleman JR; Fishman EK; Canto MI; Goggins MG; Hruban RH
    Expert Rev Gastroenterol Hepatol; 2023; 17(6):555-574. PubMed ID: 37212770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a Personalized Approach in Pancreatic Cancer Diagnostics Through Plasma Amino Acid Analysis.
    Tumas J; Baskirova I; Petrenas T; Norkuniene J; Strupas K; Sileikis A
    Anticancer Res; 2019 Apr; 39(4):2035-2042. PubMed ID: 30952747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging modalities for characterising focal pancreatic lesions.
    Best LM; Rawji V; Pereira SP; Davidson BR; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010213. PubMed ID: 28415140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.